• Something wrong with this record ?

Proceedings "Gliclazide modified release once daily in type 2 diabetes: molecular action to vascular protection"

guest editor Erol Cerasi

Published
Philadelphia : W.B. Saunders Company. A Harcourt Health Sciences Company, 2000
Series
Metabolism, ISSN 0026-0495 vol. 49, no. 10, suppl. 2, October 2000
Pagination
S25 s. : tab., grafy ; 28 cm

Language English Country United States

Document type Congress

Persistent link   https://www.medvik.cz/link/MED00078335
Supplement Parent

Metabolism: clinical and experimental : diabetes, metabolism, nutrition, lipid abnormalities, endocrinology, genetics, gout. ISSN 0026-0495

"Symposium held during the 17th International Diabetes Federation congress, Mexico, November 2000"

Bibliography, etc.

Skrytá bibl.

Owner Details Services
NLK NLK 2000 Shelf no. A 2624/49-S.3-2000 [1]
Volume Location Shelf no. Status Order
000      
01954nam 2200457 a 4500
001      
MED00078335
003      
CZ-PrNML
005      
20200414143030.0
008      
020222s2000 xxu eng||
009      
BK
020    __
$q (Brož.)
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu $c US
072    _7
$x Fyziologie člověka a srovnávací fyziologie $a 612 $2 konspekt $7 sk136312
080    __
$a 612.39 $2 h
080    __
$a 616-008 $2 h
080    __
$a 616.379-008.64 $2 h
111    2_
$a Gliclazide modified release once daily in type 2 diabetes (symposium). $d (2000 : $c Mexico)
245    10
$a Proceedings "Gliclazide modified release once daily in type 2 diabetes: molecular action to vascular protection" / $c guest editor Erol Cerasi
260    __
$a Philadelphia : $b W.B. Saunders Company. A Harcourt Health Sciences Company, $c 2000
300    __
$a S25 s. : $b tab., grafy ; $c 28 cm
490    1_
$a Metabolism, $x 0026-0495 ; $v vol. 49, no. 10, suppl. 2, October 2000
500    __
$a "Symposium held during the 17th International Diabetes Federation congress, Mexico, November 2000"
504    __
$a Skrytá bibl.
650    07
$a diabetes mellitus 2. typu $x farmakoterapie $2 czmesh $7 D003924
650    07
$a sulfonylmočovinové sloučeniny $x farmakoterapie $2 czmesh $7 D013453
650    07
$a sulfonylmočovinové sloučeniny $x terapeutické užití $2 czmesh $7 D013453
650    07
$a pankreas $x účinky léků $2 czmesh $7 D010179
650    07
$a vnitřní lékařství $2 mednas $7 nlk20040147916
655    _7
$a kongresy $2 czmesh $7 D016423
700    1_
$a Cerasi, Erol $4 edt $7 xx0058946
710    2_
$a International Diabetes Federation. $b congress $n (17. : $d 2000 : $c Mexico)
772    0_
$w MED00010225 $t Metabolism: clinical and experimental $x 0026-0495
830    _0
$a Metabolism, $x 0026-0495
910    __
$a ABA008 $b A 2624/49-S.3-2000 $y x
990    __
$a 20020222 $b ABA008
991    __
$a 20200414143024 $b ABA008
BAS    __
$a NML $a 02 $a 30 $a 12
LKV    __
$a MED00010225 $b 2000 49 Suppl. 2 $d 123922
LZP    __
$b 10